Clinical trial
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With…
NCT00200200 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00200200 |
|---|---|
| Title | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer |
| Official title | Randomized Ph II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With IV Systemic Chemo With/Without Bevacizumab (mAB to Vascular Endothelial Growth Factor-A) in Patients With Resected Hepatic Metastases From Colorectal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatic Metastases, Colon Cancer, Rectal Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab HAI plus systemic chemotherapy, HAI plus systemic chemotherapy |
| Enrollment | 73 |
| Start date | Nov 19, 2004 |
| Primary completion | Mar 13, 2025 |
| Completion | Mar 13, 2025 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 19, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: